Gene transfer therapy in vascular diseases

Cardiovascular Drug Reviews

Volumn 19, Issue 3, 2001, Pages 245-262

  McKay, Mandi J ^a   Gaballa, Mohamed A ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Gene therapy; Ischemia; Peripheral vascular disease; Restonosis; Thrombosis

Indexed keywords

ALPHA ACTIN; CHOLESTEROL ESTER; COMPLEMENTARY DNA; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; GLYCERYL TRINITRATE; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIRUDIN; KALLIKREIN; LIPOSOME; METALLOPROTEINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PLASMID DNA; PROSTACYCLIN SYNTHASE; PROTEIN P53; SCATTER FACTOR; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR GATA 6; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CLINICAL TRIAL; EDEMA; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LIMB ISCHEMIA; NONHUMAN; PARAINFLUENZA VIRUS 1; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; THROMBOSIS; VASCULAR DISEASE;

EID: 0035672214     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2001.tb00069.x     Document Type: Review

References (84)

1. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP
2. BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia
3. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis
4. The FGF family of growth factors oncogenes
5. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
6. Somatic gene therapy for dyslipidemias
7. Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models
8. Local adenovirus-mediated delivery of hirudin in a rabbit arterial injury model
9. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse
10. A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E
11. 2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty
12. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors
13. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats
14. Prospects for genetic therapy of cardiovascular disease
15. Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris
16. Efficient coexpression and secretion of anti-atherogenic human apolipoprotein Al and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors
17. The three processes leading to post PTCA restenosis: Dependence on the lesion substrate
18. Vascular beta-adrenergic receptor system is dysfunction in heart failure after myocardial infarction
19. Overexpression of endothelial nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo
20. Gene transfer of endothelial nitric oxide isoform decreases rat hindlimb vascular resistance in vivo
21. 2-adrenergic receptors in large arteries
22. Large artery remodeling in heart failure: Effects of angiotensin converting enzyme inhibition
23. Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor
24. Induction of angiogenesis by cationic lipidmediated VEGF165 gene transfer in the rabbit ischemic hindlimb model
25. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia
26. Cardiac angiogenesis and gene therapy: A strategy for myocardial revascularization
27. Functional human heme oxygenase has a neuroprotective effect on adult rat ganglion cells after pressure-induced ischemia
28. Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
29. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
30. Vascular endothelial growth factor-165 gene transfer augments circulating endothelial progenitor cells in humans
31. Transplantation of ex vivo expanded endothelial progentitor cells for therapeutic neovascularization
32. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease
33. Nitric oxide synthetase gene therapy in vascular pathology
34. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats
35. Electromagnetic guidance for catheter-based transendocardial injection: A platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models
36. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: Effect on myocardial angiogenesis
37. Adenoviral-mediated over-expression of platelet-derived growth factor-B corrects ischemic impaired wound healing
38. Recombinant adenoviral mediated gene transfer in ischemic impaired wound healing
39. Reduction in vascular lesion formation by hirudin secreted from retrovirus-transduced confluent endothelial cells on vascular grafts in baboons
40. Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals
41. Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries
42. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery
43. Gene therapy as a therapeutic intervention for vascular disease
44. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo
45. Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery
46. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty
47. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo
48. Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation
49. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit
50. Prostacyclin synthase gene transfer accelerates reendothelialization and inhibits neointimal formation in rat carotid arteries after balloon injury
51. Inability to induce hypertension in normotensive rat expressing AT(l) receptor antisense
52. Vascular permeability effect of adenovirusmediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle
53. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits
54. Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring
55. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
56. Therapeutical angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin
57. Therapeutic angiogenesis: Protein and gene therapy delivery strategies
58. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
59. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
60. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice
61. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart
62. In vivo adenovirus-mediated gene transfer and expression in ischemic rabbit spinal cord
63. P53 gene transfer to the injured rat carotid artery promotes apoptosis
64. p53 gene transfer to the injured rat carotid artery decreases neointimal formation
65. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
66. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
67. Efficient inhibition of intimal hyperplasia by adenovirusmediated inducible oxide synthase gene transfer to rats and pigs in vivo
68. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: Prospects for gene therapy of ischemia-induced neuronal death
69. Gene therapy in the cardiovascular system: An update
70. Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts
71. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
72. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension
73. Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats
74. Gene therapy for angiogenesis, restenosis and related diseases
75. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
76. Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries
77. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats
78. Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA
79. Thrombomodulin overexpression to limit neointima formation
80. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model
81. Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: Potential application of ribozyme strategy to treat cardiovascular disease
82. Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist
83. Gene therapy of vascular diseases
84. Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor